Key Highlights
- Synopsys (NASDAQ:SNPS) traded at USD 480.06, up 10.37 percent in the screener snapshot on October 1, 2026, after its Investor Day in New York on September 30.
- Fiscal 2027 Revenue guidance is USD 11.15 billion at the midpoint, up about 15 percent, with non-GAAP EPS of USD 19.04 to USD 19.12 and free Cash Flow near USD 3.1 billion.
- A multi-year agreement with the cloud arm of Amazon (NASDAQ:AMZN), valued at more than USD 1 billion, licenses Synopsys silicon IP and software for custom chips.
- The company plans to repurchase about USD 1 billion of shares in coming months, up to 50 percent of free cash flow, and raised long-term targets to mid-teens growth through fiscal 2030.
The Cloud Deal and License Plus Royalty
Under the agreement, Amazon (NASDAQ:AMZN) will license Synopsys silicon intellectual property and engineering software for custom chips including Nitro, Graviton and Trainium processors, and becomes lead customer for the expanded application-optimized IP business. The structure is license plus royalty: royalties scale with the customer's chip volumes, so revenue grows as production grows rather than as a fixed fee. Neither company has disclosed a recognition schedule or Royalty rate. Synopsys also announced a Partnership with OpenAI to build GPT-Synopsys, a model for semiconductor design workflows.
Guidance, Targets and Buyback
Synopsys (NASDAQ:SNPS) raised its long-term objectives to mid-teens annual revenue growth through fiscal 2030, an Operating Margin near 50 percent and mid-20s percent growth in EPS and free cash flow. Fiscal 2027 guidance arrived about two and a half months earlier than usual: revenue of USD 11.1 billion to USD 11.2 billion against prior consensus near USD 10.8 billion, non-GAAP operating margin of about 44 percent and GAAP EPS of USD 8.16 to USD 8.61. Ansys cost synergies of USD 400 million should be reached in fiscal 2027, a year early.
Valuation and Risks
Wells Fargo raised its price target to USD 540 from USD 475 on October 1, and Morgan Stanley upgraded the stock to Overweight in early September. The shares moved from about USD 435 to USD 480.06, a gain of about 10 percent, simple arithmetic on the screener figures, so expectations are higher. Risks include customer concentration in custom silicon, a royalty model that depends on partners' chip volumes, integration of the Ansys acquisition, and a wide GAAP gap: fiscal 2027 GAAP EPS of up to USD 8.61 is far below non-GAAP EPS because of amortization and stock compensation.
Where Things Stand
Synopsys (NASDAQ:SNPS) rose because three things arrived at once: a USD 1 billion customer, fiscal 2027 guidance above consensus and a USD 1 billion buyback. The royalty structure could make growth less cyclical, but it depends on partner chip volumes. GAAP Earnings are much lower than non-GAAP, and the stock has already moved about 10 percent today. The next checkpoint is fiscal fourth-quarter results, which will be measured against these new targets.





_11_18_2026_15_37_14_813718.jpg)
Please wait processing your request...